Earnings History Data for Traws Pharma, Inc. (TRAW) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Traws Pharma, Inc.

Traws Pharma Inc. is involved in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Traws Pharma Inc., formerly known as Onconova Therapeutics Inc., is based in NEWTOWN, Pa.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	AH	TRAW	Traws Pharma, Inc.	11.00	-8.81	-6.25	0.00	Traws Pharma GAAP EPS of -$8.81, revenue of $0.06M in-line [11/14/2024 4:59 PM]	4.90	-0.68 (-12.22%)	0.0	0.0 (0.00%)	4.44 - 27.50	5,548	10,000	0
Traws Pharma GAAP EPS of -$8.81, revenue of $0.06M in-line [11/14/2024 4:59 PM] Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results [Nov-14-24 04:30PM]
15-05-2024	AH	TRAW	Traws Pharma, Inc.	16.00	-0.24	-0.24	0.00	Onconova Therapeutics GAAP EPS of -$0.24 beats by $0.01, revenue of $0.06M in-line [5/16/2024 1:07 PM]	0.6584	0.0 (0.15%)	0.66	0.0 (0.76%)	0.55 - 1.33	48,290	50,000	1,977
Onconova Therapeutics GAAP EPS of -$0.24 beats by $0.01, revenue of $0.06M in-line [5/16/2024 1:07 PM]